Retinopathy of prematurity screening and treatment cost in Brazil
OBJECTIVE: To assess the additional cost of incorporating the detection and treatment of retinopathy of prematurity (ROP) into neonatal care services of Brazil's Unified Health System (SUS). METHODS: A deterministic decision-tree simulation model was built to estimate the direct costs of screen...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pan American Health Organization
2014-07-01
|
Series: | Revista Panamericana de Salud Pública |
Subjects: | |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892014000600006&lng=en&tlng=en |
id |
doaj-52388a06536946ebbdd50dd8abae2adb |
---|---|
record_format |
Article |
spelling |
doaj-52388a06536946ebbdd50dd8abae2adb2020-11-25T00:12:37ZengPan American Health OrganizationRevista Panamericana de Salud Pública1020-49892014-07-013613743S1020-49892014000600006Retinopathy of prematurity screening and treatment cost in BrazilAndrea A. Zin0Cynthia Magluta1Márcia F. T. Pinto2Aline P. Entringer3Maria A. Mendes-Gomes4Maria E. L. Moreira5Clare Gilbert6Fundação Oswaldo Cruz (Fiocruz)Fundação Oswaldo Cruz (Fiocruz)Fundação Oswaldo Cruz (Fiocruz)Fundação Oswaldo Cruz (Fiocruz)Fundação Oswaldo Cruz (Fiocruz)Fundação Oswaldo Cruz (Fiocruz)International Centre for Eye HealthOBJECTIVE: To assess the additional cost of incorporating the detection and treatment of retinopathy of prematurity (ROP) into neonatal care services of Brazil's Unified Health System (SUS). METHODS: A deterministic decision-tree simulation model was built to estimate the direct costs of screening for and treating ROP in neonatal intensive-care units (NICUs), based on data for 869 preterm infants with birth weight less than 1 500 g examined in six governmental NICUs in the capital city of Rio de Janeiro, where coverage was 52% and 8% of infants were treated. All of the parameters from this study were extrapolated to Brazilian newborn estimates in 2010. Costs of screening and treatment were estimated considering staff, equipment and maintenance, and training based on published data and expert opinion. A budget impact analysis was performed considering the population of preterm newborns, screening coverage, and the incidence of treatable ROP. One- and two-way sensitivity analyses were performed. RESULTS: In Rio de Janeiro, unit costs per newborn were US$ 18 for each examination, US$ 398 per treatment, and US$ 29 for training. The estimated cost of ROP diagnosis and treatment for all at-risk infants NICUs was US$ 80 per infant. The additional cost to the SUS for one year would be US$ 556 640 for a ROP program with 52% coverage, increasing to US$ 856 320 for 80% coverage, and US$ 1.07 million or 100% coverage. CONCLUSIONS: The results of this study indicate that providing ROP care is affordable within the framework of the SUS in Brazil, and might be feasible elsewhere in Latin America, considering the evidence of the effectiveness of ROP treatment and the social benefits achieved.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892014000600006&lng=en&tlng=enCostos y análisis de costoretinopatía de la prematuridadBrasil |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrea A. Zin Cynthia Magluta Márcia F. T. Pinto Aline P. Entringer Maria A. Mendes-Gomes Maria E. L. Moreira Clare Gilbert |
spellingShingle |
Andrea A. Zin Cynthia Magluta Márcia F. T. Pinto Aline P. Entringer Maria A. Mendes-Gomes Maria E. L. Moreira Clare Gilbert Retinopathy of prematurity screening and treatment cost in Brazil Revista Panamericana de Salud Pública Costos y análisis de costo retinopatía de la prematuridad Brasil |
author_facet |
Andrea A. Zin Cynthia Magluta Márcia F. T. Pinto Aline P. Entringer Maria A. Mendes-Gomes Maria E. L. Moreira Clare Gilbert |
author_sort |
Andrea A. Zin |
title |
Retinopathy of prematurity screening and treatment cost in Brazil |
title_short |
Retinopathy of prematurity screening and treatment cost in Brazil |
title_full |
Retinopathy of prematurity screening and treatment cost in Brazil |
title_fullStr |
Retinopathy of prematurity screening and treatment cost in Brazil |
title_full_unstemmed |
Retinopathy of prematurity screening and treatment cost in Brazil |
title_sort |
retinopathy of prematurity screening and treatment cost in brazil |
publisher |
Pan American Health Organization |
series |
Revista Panamericana de Salud Pública |
issn |
1020-4989 |
publishDate |
2014-07-01 |
description |
OBJECTIVE: To assess the additional cost of incorporating the detection and treatment of retinopathy of prematurity (ROP) into neonatal care services of Brazil's Unified Health System (SUS). METHODS: A deterministic decision-tree simulation model was built to estimate the direct costs of screening for and treating ROP in neonatal intensive-care units (NICUs), based on data for 869 preterm infants with birth weight less than 1 500 g examined in six governmental NICUs in the capital city of Rio de Janeiro, where coverage was 52% and 8% of infants were treated. All of the parameters from this study were extrapolated to Brazilian newborn estimates in 2010. Costs of screening and treatment were estimated considering staff, equipment and maintenance, and training based on published data and expert opinion. A budget impact analysis was performed considering the population of preterm newborns, screening coverage, and the incidence of treatable ROP. One- and two-way sensitivity analyses were performed. RESULTS: In Rio de Janeiro, unit costs per newborn were US$ 18 for each examination, US$ 398 per treatment, and US$ 29 for training. The estimated cost of ROP diagnosis and treatment for all at-risk infants NICUs was US$ 80 per infant. The additional cost to the SUS for one year would be US$ 556 640 for a ROP program with 52% coverage, increasing to US$ 856 320 for 80% coverage, and US$ 1.07 million or 100% coverage. CONCLUSIONS: The results of this study indicate that providing ROP care is affordable within the framework of the SUS in Brazil, and might be feasible elsewhere in Latin America, considering the evidence of the effectiveness of ROP treatment and the social benefits achieved. |
topic |
Costos y análisis de costo retinopatía de la prematuridad Brasil |
url |
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892014000600006&lng=en&tlng=en |
work_keys_str_mv |
AT andreaazin retinopathyofprematurityscreeningandtreatmentcostinbrazil AT cynthiamagluta retinopathyofprematurityscreeningandtreatmentcostinbrazil AT marciaftpinto retinopathyofprematurityscreeningandtreatmentcostinbrazil AT alinepentringer retinopathyofprematurityscreeningandtreatmentcostinbrazil AT mariaamendesgomes retinopathyofprematurityscreeningandtreatmentcostinbrazil AT mariaelmoreira retinopathyofprematurityscreeningandtreatmentcostinbrazil AT claregilbert retinopathyofprematurityscreeningandtreatmentcostinbrazil |
_version_ |
1725398617849593856 |